We want to ensure optimum use of our website for you, and to continually improve our website. Therefore, we work with selected partners (e.g. Pardot). You can revoke your voluntary consent at any time. You can find further information and setting options under „Configure“ and in our data protection information.
Elekta’s annual report 2011/12 has been published and can be downloaded from the investor section on the Elekta web, www.elekta.com, and is also enclosed with this press release.
The printed annual report is under distribution to the shareholders who have requested to receive it. Elekta’s Annual General Meeting takes place September 4, 2012, at 3:00 p.m. at Stockholm Waterfront Congress Centre.
To request hardcopies of Elekta’s annual report for 2011/12 in Swedish or English,please visit www.elekta.com.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37,
Johan Andersson Melbi, Investor Relations Manager, Elekta AB
Tel: +46 702 100 451,